Last week I gave two presentations in Asia. On Monday, I presented The Law and Economics of Wrongful Patent Assertion at IEEM (Instituto de Estudos Europeus de Macau)’s 20th Intellectual Property Seminar, “Proportionality in Intellectual Property Law,” in Macau, S.A.R. The presentation summarized some of my current book project, Wrongful Patent Assertion: A Comparative Law […]
Last week’s conferences in Asia Read More »
The United States Patent and Trademark Office (USPTO) has implemented significant changes to its trademark filing fee structure, effective January 18, 2025. These changes represent a fundamental shift from the previous two-tier system to a single base fee with potential surcharges for complex applications. NEW BASE FEE STRUCTURE The USPTO has consolidated its previous Trademark
USPTO’s New Trademark Fees Expected to Impact Filing Costs | Stinson LLP Read More »
Last week I gave two presentations in Asia. On Monday, I presented The Law and Economics of Wrongful Patent Assertion at IEEM (Instituto de Estudos Europeus de Macau)’s 20th Intellectual Property Seminar, “Proportionality in Intellectual Property Law,” in Macau, S.A.R. The presentation summarized some of my current book project, Wrongful Patent Assertion: A Comparative Law
Last week’s conferences in Asia Read More »
Last week I gave two presentations in Asia. On Monday, I presented The Law and Economics of Wrongful Patent Assertion at IEEM (Instituto de Estudos Europeus de Macau)’s 20th Intellectual Property Seminar, “Proportionality in Intellectual Property Law,” in Macau, S.A.R. The presentation summarized some of my current book project, Wrongful Patent Assertion: A Comparative Law
Last week’s conferences in Asia Read More »
By Andrew Karpan ( January 17, 2025, 8:05 PM EST) — A federal judge in Illinois has found that Charles Walgreen didn’t break the terms of a deal he made a decade ago to not compete with the retail and pharmacy giant that his great-grandfather founded, which is now suing him over his commercial use
Walgreens Can’t Hold Great-Grandson To Decade-Old TM Deal Read More »
This case examines the application of trademark functionality doctrine in the medical device industry, specifically addressing whether the pink color of ceramic hip components can be protected as a trademark. The case provides important guidance on how courts evaluate functionality claims and the intersection between patent and trademark protection for product features. Background Ceramtec manufactures
Ceramtec GMBH v. Coorstek Biocermanics LLC | Sheppard Mullin Richter & Hampton LLP Read More »
Last week I gave two presentations in Asia. On Monday, I presented The Law and Economics of Wrongful Patent Assertion at IEEM (Instituto de Estudos Europeus de Macau)’s 20th Intellectual Property Seminar, “Proportionality in Intellectual Property Law,” in Macau, S.A.R. The presentation summarized some of my current book project, Wrongful Patent Assertion: A Comparative Law
Last week’s conferences in Asia Read More »
The USPTO is restructuring its electronic trademark filing process by replacing the current TEAS Plus and TEAS Standard options with a single streamlined electronic application. Under the new system, the separate fees for TEAS Plus and TEAS Standard applications, as well as the processing fee for non-compliance with TEAS Plus requirements, will be discontinued. Instead,
Last week I gave two presentations in Asia. On Monday, I presented The Law and Economics of Wrongful Patent Assertion at IEEM (Instituto de Estudos Europeus de Macau)’s 20th Intellectual Property Seminar, “Proportionality in Intellectual Property Law,” in Macau, S.A.R. The presentation summarized some of my current book project, Wrongful Patent Assertion: A Comparative Law
Last week’s conferences in Asia Read More »
By Hayley Fowler ( January 17, 2025, 7:39 PM EST) — A biotechnology company can’t stop its co-founder from conducting research and soliciting customers at his new company using what it believes is stolen confidential information, a North Carolina state court judge said Friday, pointing to a lack of urgency and glaring holes in the
NC Biotech Co. Can’t Restrain Co-Founder’s Rival Business Read More »